+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Topical Absorbable Hemostats - Medical Devices Pipeline Assessment, 2020

  • PDF Icon

    Report

  • 208 Pages
  • August 2020
  • Region: Global
  • GlobalData
  • ID: 5135643
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

Summary

The Medical Devices sector report, “Topical Absorbable Hemostats - Medical Devices Pipeline Assessment, 2020" provides comprehensive information about the Topical Absorbable Hemostats pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress.

Topical Absorbable Hemostats are agents used to promote and accelerate hemostasis to control bleeding in cases where application of pressure, ligature and other conventional methods is ineffective.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Topical Absorbable Hemostats under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Topical Absorbable Hemostats and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to Buy

The report enables you to:
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Topical Absorbable Hemostats under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date

Table of Contents

Introduction
Products under Development
  • Topical Absorbable Hemostats - Pipeline Products by Stage of Development
  • Topical Absorbable Hemostats - Pipeline Products by Segment
  • Topical Absorbable Hemostats - Pipeline Products by Territory
  • Topical Absorbable Hemostats - Pipeline Products by Regulatory Path
  • Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date
  • Topical Absorbable Hemostats - Ongoing Clinical Trials

Topical Absorbable Hemostats - Pipeline Products under Development by Companies
  • Topical Absorbable Hemostats Companies - Pipeline Products by Stage of Development
  • Topical Absorbable Hemostats - Pipeline Products by Stage of Development

Topical Absorbable Hemostats Companies and Product OverviewTopical Absorbable Hemostats- Recent DevelopmentsAppendix
List of Tables
Table 1: Topical Absorbable Hemostats - Pipeline Products by Stage of Development
Table 2: Topical Absorbable Hemostats - Pipeline Products by Segment
Table 3: Topical Absorbable Hemostats - Pipeline Products by Territory
Table 4: Topical Absorbable Hemostats - Pipeline Products by Regulatory Path
Table 5: Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date
Table 6: Topical Absorbable Hemostats - Ongoing Clinical Trials
Table 7: Topical Absorbable Hemostats Companies - Pipeline Products by Stage of Development
Table 8: Topical Absorbable Hemostats - Pipeline Products by Stage of Development
Table 9: 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview
List of Figures
Figure 1: Topical Absorbable Hemostats - Pipeline Products by Stage of Development
Figure 2: Topical Absorbable Hemostats - Pipeline Products by Segment
Figure 3: Topical Absorbable Hemostats - Pipeline Products by Territory
Figure 4: Topical Absorbable Hemostats - Pipeline Products by Regulatory Path
Figure 5: Topical Absorbable Hemostats - Pipeline Products by Estimated Approval Date
Figure 6: Topical Absorbable Hemostats - Ongoing Clinical Trials

Companies Mentioned

A selection of companies mentioned in this report includes:

  • 3-D Matrix Ltd
  • Angiotech Pharmaceuticals Inc
  • Anika Therapeutics Inc
  • APRUS Bio-Medical Innovations Pvt Ltd
  • Arch Therapeutics Inc
  • Baxter Healthcare Corp
  • Baxter International Inc
  • Beth Israel Deaconess Medical Center Inc
  • Biomedica Management Corp
  • Biom'Up SAS
  • Cellphire Inc
  • Ceramicos Para Aplicacoes Medicas SA
  • Columbia University
  • Covalent Medical, Inc. (Inactive)
  • Covalon Technologies Ltd
  • CR Bard Inc
  • Cresilon Inc
  • CryoLife Inc
  • Endomedix Incorporated
  • Entegrion Inc
  • Ethicon US LLC
  • ETX Pharma Inc
  • Gamma Therapeutics Inc
  • GATT Technologies BV
  • Haemostatix Ltd
  • Hemostasis LLC
  • HLL Lifecare Ltd
  • Keratin Biosciences Inc
  • Leader Biomedical Europe BV
  • Medcura Inc
  • Protege Biomedical
  • Resorba GmbH
  • Rice University
  • Sanara MedTech Inc
  • Sanofi Biosurgery Inc
  • Sea Run Holdings Inc
  • St Teresa Medical Inc
  • STB Lifesaving Technologies
  • Tectum
  • The Medicines Co
  • Therus Corporation
  • Thrombotargets Corp
  • United Health Products, Inc.
  • University of Grenoble Alpes
  • Virginia Commonwealth University
  • Xcede Technologies Inc